Qiagen announced “that Bode Technology, the largest private U.S. forensics laboratory company with a growing presence in other regions, would become the exclusive global commercial partner for the GEDmatch PRO genealogy database, which is used to assist police and forensic teams with investigative comparisons of genetic data.” The multi-year agreement between QIAGEN’s subsidiary Verogen and Bode extends the long-standing partnership of two leading companies in forensic investigative genetic genealogy or FIGG, to further accelerate the use of GEDmatch PRO in law enforcement and identification of human remains. QIAGEN has been providing GEDmatch PRO to customers since the early 2023 acquisition of its subsidiary Verogen, a proven leader in equipping forensic science laboratories and criminal investigators to use next-generation sequencing,NGS, to gain deeper insights…As part of the partnership, Bode will manage all commercial transactions for GEDmatch PRO globally, while QIAGEN will continue to develop new features with input from Bode’s genealogy experts. Bode will maintain the highest level of data security as GEDmatch PRO users will continue to own their case data and no additional identifying information will be shared with Bode. QIAGEN’s subsidiary will continue to have sole responsibility and manage the separate GEDmatch consumer database and its free DNA comparison-and-analysis website, which are not affected by this partnership.